Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.16
Delayed Data
As of Feb 27
 -0.03 / -2.52%
Today’s Change
0.91
Today|||52-Week Range
6.50
-27.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

--

--
Operating ActivitiesNet Income / Starting Line-12.9M-20.9M----
 
 
 
Depreciation147.0K99.0K----
 
 
 
Total Other Cash Flow7.1M14.2M----
 
 
 
Funds From Operations-5.6M-6.6M----
 
 
 
Funds From/For Other Operating Expenses-525.0K-286.0K----
 
 
 
Net Cash Flow - Operating Activities-5.1M-6.3M----
 
 
 
 
InvestingIncrease In Investments0.00-9.0M----
 
 
Decrease In Investments0.006.0M----
 
 
Capital Expenditures-15.0K-78.0K----
 
 
 
Fixed Asset Disposal33.0K0.00----
 
 
Other Investing - Uses-2.0K-18.0K----
 
 
 
Other Investing - Sources0.003.0K----
 
 
Net Cash Flow Investing16.0K-3.1M----
 
 
 
 
FinancingShort Term Borrowings0.00-5.0K----
 
 
Long Term Borrowings500.0K0.00----
 
 
Long Term Debt Reduction-29.0K0.00----
 
 
Net Proceeds Stock Sale9.2M15.7M----
 
 
 
Common Preferred Redeemed0.00-12.0K----
 
 
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.00------
Other Uses - Financing0.000.00------
Net Cash Flow - Financing9.7M15.7M----
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash4.6M6.3M----
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account